IN2014CN04222A - - Google Patents
Info
- Publication number
- IN2014CN04222A IN2014CN04222A IN4222CHN2014A IN2014CN04222A IN 2014CN04222 A IN2014CN04222 A IN 2014CN04222A IN 4222CHN2014 A IN4222CHN2014 A IN 4222CHN2014A IN 2014CN04222 A IN2014CN04222 A IN 2014CN04222A
- Authority
- IN
- India
- Prior art keywords
- present
- therapeutic agent
- phosphatidic acid
- joint diseases
- destruction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 | ||
| PCT/JP2012/076478 WO2013069404A1 (ja) | 2011-11-11 | 2012-10-12 | 関節症治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04222A true IN2014CN04222A (ru) | 2015-07-17 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4222CHN2014 IN2014CN04222A (ru) | 2011-11-11 | 2012-10-12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9085593B2 (ru) |
| EP (1) | EP2803359B1 (ru) |
| JP (1) | JP5465815B2 (ru) |
| KR (1) | KR101953181B1 (ru) |
| CN (1) | CN103906519B (ru) |
| AU (1) | AU2012337087B2 (ru) |
| BR (1) | BR112014011315B8 (ru) |
| CA (1) | CA2855660C (ru) |
| ES (1) | ES2634008T3 (ru) |
| HK (1) | HK1199406A1 (ru) |
| IN (1) | IN2014CN04222A (ru) |
| MY (1) | MY168931A (ru) |
| RU (1) | RU2646457C2 (ru) |
| SG (1) | SG11201402226PA (ru) |
| WO (1) | WO2013069404A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI733108B (zh) | 2014-08-12 | 2021-07-11 | 日商大塚化學股份有限公司 | 環狀膦酸鈉鹽之結晶及其製造方法 |
| JPWO2021132297A1 (ru) | 2019-12-23 | 2021-07-01 | ||
| WO2022114058A1 (ja) | 2020-11-26 | 2022-06-02 | Ｓａｎｓｈｏ株式会社 | 肺線維症治療剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (ja) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | 車両感知器 |
| JP3195833B2 (ja) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | 新規生理活性物質及びその製造法 |
| JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素ｃの活性促進剤 |
| JPH07258278A (ja) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤 |
| JPH0925235A (ja) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| JP2001178489A (ja) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | 環状ホスファチジン酸の製造法 |
| JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
| JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤 |
| EP1402894B1 (en) | 2001-05-21 | 2007-12-26 | Kimiko Murofushi | Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives |
| JP4162927B2 (ja) | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
| CA2521189A1 (en) * | 2003-04-11 | 2004-10-28 | Gabor Tigyi | Lysophosphatidic acid analogs and inhibition of neointima formation |
| CA2598456A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| CN101610775B (zh) * | 2006-12-28 | 2012-12-12 | 国立大学法人御茶水女子大学 | 含有环状磷脂酸衍生物的镇痛剂 |
| JP2010189315A (ja) | 2009-02-18 | 2010-09-02 | Unitika Ltd | 関節軟骨損傷治癒促進剤及びそれを含有する飲食品 |
-
2012
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/zh active Active
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/ja active Application Filing
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/pt active IP Right Grant
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/ru active
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/es active Active
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/ko active IP Right Grant
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/ja active Active
-
2014
- 2014-12-29 HK HK14113014.9A patent/HK1199406A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201402226PA (en) | 2014-10-30 |
| JPWO2013069404A1 (ja) | 2015-04-02 |
| KR101953181B1 (ko) | 2019-02-28 |
| ES2634008T3 (es) | 2017-09-26 |
| BR112014011315B1 (pt) | 2020-03-03 |
| AU2012337087A1 (en) | 2014-06-05 |
| WO2013069404A1 (ja) | 2013-05-16 |
| HK1199406A1 (en) | 2015-07-03 |
| EP2803359A4 (en) | 2015-12-16 |
| MY168931A (en) | 2019-01-09 |
| CA2855660C (en) | 2019-04-16 |
| US9085593B2 (en) | 2015-07-21 |
| BR112014011315A2 (pt) | 2017-05-09 |
| KR20140098778A (ko) | 2014-08-08 |
| RU2646457C2 (ru) | 2018-03-05 |
| EP2803359B1 (en) | 2017-04-19 |
| US20140309194A1 (en) | 2014-10-16 |
| NZ624870A (en) | 2016-01-29 |
| CA2855660A1 (en) | 2013-05-16 |
| EP2803359A1 (en) | 2014-11-19 |
| AU2012337087B2 (en) | 2016-11-17 |
| RU2014123690A (ru) | 2015-12-20 |
| CN103906519A (zh) | 2014-07-02 |
| CN103906519B (zh) | 2017-10-10 |
| JP5465815B2 (ja) | 2014-04-09 |
| BR112014011315B8 (pt) | 2020-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024202233A1 (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
| PE20151727A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| IN2012DN06720A (ru) | ||
| TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
| MX2019003693A (es) | Formulaciones de insulina de accion prolongada. | |
| CR20140567A (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas | |
| MY163083A (en) | Solid forms of a pharmaceutically active substance | |
| MX2015002669A (es) | Metodos de administracion de tratamiento con pirfenidona. | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX2016000794A (es) | Composiciones farmaceuticas de pancreatina de potencia alta. | |
| IN2015DN01151A (ru) | ||
| GEP201706621B (en) | Benzamides | |
| MX364220B (es) | Metodos de tratamientos de fibrosis. | |
| MX2016000480A (es) | Composiciones farmaceuticas de pancreatina de alta potencia. | |
| JO3388B1 (ar) | تركيبة دوائية ثابتة للإعطاء عن طريق الفم تضم ليفوسيتيريزين أو ملح منه مقبول دوائياً، و منتولوكاست أو ملح منه مقبول دوائياً | |
| MY173491A (en) | Therapeutic or prophylactic agent for biliary tract diseases | |
| MX336333B (es) | Nueva forma cristalina de un derivado de ciclopropilbenzamida. | |
| BR112015011693A2 (pt) | composições fibrinolíticas compreendendo bromelina e nattokinase para a prevenção e tratamento de estados flebotrombóticos | |
| IN2014CN04222A (ru) | ||
| MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
| IN2014DN03010A (ru) | ||
| IN2014CN04119A (ru) | ||
| TR201200215A2 (tr) | Geliştirilmiş farmasötik formülasyonlar. | |
| TR201200212A2 (tr) | Risedronat içeren geliştirilmiş formülasyonlar. |